EFFECTS OF METABOLIC PHARMACOTHERAPY IN REAL WORLD PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

被引：0
|
作者：
Eghbali, Shabnam [1 ]
Newberry, Carolyn [2 ]
Yeung, Michele [3 ]
Sharaiha, Reem [2 ]
Kumar, Sonal [2 ]
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Weill Cornell Med, Gastroenterol & Hepatol, New York, NY USA
[3] Weill Cornell Med, Endocrinol Diabet & Metab, New York, NY USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2624
引用
收藏
页码：S847 / S847
页数：1
相关论文
共 50 条
  • [1] Metabolic syndrome (MS) in non-alcoholic fatty liver disease (NAFLD)
    Bugianesi, E
    Marchesini, G
    Manini, R
    Moscatiello, S
    Striuli, L
    Vanni, E
    Gentilcore, E
    Zanotti, E
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 191 - 191
  • [2] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [3] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [4] Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
    Samarasinghe, Saumya Madushani
    Hewage, Asanka Sudeshini
    Siriwardana, Rohan Chaminda
    Tennekoon, Kamani Hemamala
    Niriella, Madunil Anuk
    De Silva, Sumadee
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2023, 24 (01)
  • [5] Is non-alcoholic fatty liver disease (NAFLD) an independent predictor of the metabolic syndrome
    Zelber-Sagi, S
    Nitzan-Kaluski, D
    Halpern, Z
    Webb, M
    Oren, R
    HEPATOLOGY, 2005, 42 (04) : 617A - 617A
  • [6] IMPACT OF METABOLIC SYNDROME ON THE PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Mohanty, Smruti R.
    Lee, Ye-Jin
    Mishra, Poonam
    Hart, John
    Te, Helen S.
    Reau, Nancy
    Reddy, K. Gautham
    Satoskar, Rohit S.
    Jensen, Donald M.
    HEPATOLOGY, 2008, 48 (04) : 824A - 824A
  • [7] Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
    Saumya Madushani Samarasinghe
    Asanka Sudeshini Hewage
    Rohan Chaminda Siriwardana
    Kamani Hemamala Tennekoon
    Madunil Anuk Niriella
    Sumadee De Silva
    Egyptian Journal of Medical Human Genetics, 24
  • [8] In Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Metabolic Conditions are Independently Associated with Mortality
    Younossi, Zobair M.
    Otgonsuren, Munkhzul
    Locklear, Cameron T.
    Venkatesan, Chapy
    Mishra, Alita
    Erario, Madeline
    Srishord, Manirath
    Racila, Andrei
    Arsalla, Aimal
    Kalwaney, Shirley K.
    HEPATOLOGY, 2015, 62 : 495A - 495A
  • [9] Updates in non-alcoholic fatty liver disease (NAFLD)
    McNeice, Krista
    Sandberg, Kelly
    CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE, 2020, 50 (08)
  • [10] SARCOPENIA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Yerragorla, Priyanka
    Nepal, Pankaj
    Nekkalapudi, Divya
    Andreias, Laura
    Ahmed, Shady
    Dabas, Ritu
    Mousavi, Ali
    Morcos, Morcos
    Matari, Hussein
    Harley, Jennifer
    Bergasa, Nora V.
    GASTROENTEROLOGY, 2018, 154 (06) : S1174 - S1175
12345